e-Health

In February 2025, seven health apps reached Level 3+ of the mHealthBelgium validation pyramid, meaning regular reimbursement. These apps can only be reimbursed within the specific care pathway “Remote monitoring and therapeutic guidance in chronic heart failure”.

On January 24, 2025, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for projects on new forms of care (for single-stage process – open topic and for two-stage process – nine topics).

In January 2025, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedures Guidance (Transperineal laser ablation for lower urinary tract symptoms of benign prostatic hyperplasia, electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder) and one new Early Value Assessment (Artificial intelligence technologies to help detect fractures on X-rays in urgent care). Furthermore, one new clinical guideline was published, and one was updated.

The Federal Ministry of Health summarized multiple changes in the healthcare system that will be introduced in 2025. The most important ones relate to the further steps in digitalizing healthcare and hospital reform.

In December 2024, MTRC reported that the first health app had entered Level 3+ of the mHealthBelgium validation pyramid, indicating eligibility for regular reimbursement. However, no health apps are currently listed at Level 3 on the validation pyramid. mHealthBelgium clarified to MTRC that the December 2024 listing was part of a visual test to demonstrate how an app would appear at Level 3 on their website. They anticipate that the first apps will officially reach Level 3 by the end of January 2025.

In December 2024, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedures Guidance (Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implant, MRI-guided focused ultrasound subthalamotomy and thalamotomy for treating Parkinson’s), one new Diagnostic Guidance (Home-testing devices for diagnosing OSAHS) and one new Early Value Assessment (Digital technologies to support self-management of COPD).

In December 2024, the Danish Board for Health Apps published information on how to apply for the health app evaluation, including the electronic form for the application to the Board of Health Apps, the assessment criteria, and details of the application process.

In late November 2024, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions recommending the transfer to standard care for two completed projects. The projects were dedicated to relieving the burden of emergency rooms and improving infection surveillance in nursing homes.

In December 2024, the National Institute for Health and Disability Insurance (INAMI/RIZIV) launched a new agreement (Convention) allowing reimbursement for remote monitoring of patients with chronic heart failure. It will come into force on January 1, 2025. New codes (pseudonomenclature) with fees for packages of care will be used for reimbursement. The packages include monitoring of clinical parameters by patients at home (e.g., blood pressure measurement or pulmonary artery pressure measured by an implanted sensor) and transmission of data via a health app to the remote monitoring team at the hospital.

On November 6, 2024, the first meeting of the Board for Health Apps was held in Denmark. As soon as the Board determines the criteria according to which it will assess health apps, it will be possible to apply for assessment followed by recommendations

In November 2024, the following ongoing mini-HTA assessments for cardiovascular, diagnostic imaging, e-health, gastrointestinal, in-vitro diagnostics, interventional radiology, men’s health, pulmonary and airways, robotic surgery, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway.

In November 2024, NICE introduced CHEERS-AI - a new reporting standard for health economic evaluations of AI technologies. This will help healthcare decision-makers understand the value of AI-enabled treatments, allowing patients to access the most promising ones faster.